Erratum: Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway: Erratum

Theranostics. 2022 Nov 2;12(17):7645. doi: 10.7150/thno.78949. eCollection 2022.

Hui-Juan Liu^{1

2}, Yuan Qin^{1

2}, Zi-Han Zhao^{1

2}, Yang Zhang³, Jia-Huan Yang^{1

2}, Deng-Hui Zhai^{1

2}, Fang Cui^{1

2}, Ce Luo¹, Man-Xi Lu¹, Piao-Piao Liu¹, Heng-Wei Xu^{1

2}, Kun Li^{1

2}, Bo Sun², Shuang Chen², Hong-Gang Zhou¹, Cheng Yang^{1

2}, Tao Sun^{1

2

4}

¹ State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
² Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
³ Department of Anesthesiology, Tianjin Fourth Central Hospital, Tianjin, China.
⁴ Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin Institute of Digestive Disease, Tianjin, China.

Abstract

[This corrects the article DOI: 10.7150/thno.46467.].